INS and Alzheimer disease: The measurement of pathway activities showed that neurological pathways (neurological diseases, addiction-related pathways, and synaptic functions) and metabolic pathways (oxidative phosphorylation, amino acid metabolism, and the insulin pathway) were downregulated, whereas immune disease-related pathways were markedly upregulated in AD.